Treatment Patterns and Perceptions of Treatment Attributes, Satisfaction and Effectiveness Among Patients With Psoriasis
August 2010 | Volume 9 | Issue 8 | Original Article | 938 | Copyright © August 2010
Marco daCosta DiBonaventura PhD, Samuel Wagner PhD RP, Heidi C. Waters MS, MBA, Chureen Carter PharmD, MS
Psoriasis is a chronic autoimmune condition that affects over 7 million Americans, approximately 1–3 percent of the population.
Although there are a number of treatment options currently available, little is known about the treatment patterns of patients. Using
data from 1,006 psoriasis sufferers, the aim of the present study was to analyze patients’ treatment timeline, as well as their
perceptions about these treatments. Most respondents were white, female and had health insurance. The results suggested that
over-the-counter (OTC) and prescription topicals were the most common initial treatments, but systemic orals and biologics were
the most common treatments for patients who required a third-line or fourth-line treatment (and for patients with greater severity).
Treatment dissatisfaction was relatively high, with very few positive attributes associated with the current treatment options. Overall,
this study suggests that treatment options vary (at a statistically significant level) as a function of severity, and many patients, despite
the choices in the number and quality of treatment options, are generally dissatisfied.